Event

Apply pharmaceutical reimbursement systems in Europe to pricing and reimbursement decision-making

This course provides an in-depth exploration of pharmaceutical reimbursement systems across Europe, examining the decision-making processes that determine whether and how new medicines are reimbursed and made accessible in different countries. It explores how national healthcare priorities, regulatory frameworks, and reimbursement policies influence pricing and market access decisions.

Technical topics include:

• Key features of pharmaceutical reimbursement systems across European countries
• The roles of national health insurers, Ministries of Health, and other decision-making bodies
• Differences between European marketing authorization and national pricing and reimbursement processes
• Factors influencing reimbursement decisions, including healthcare priorities, regulatory frameworks, and market dynamics
• The impact of monopsony purchasing by public health insurers and monopoly market conditions for pharmaceutical manufacturers

This course includes tools and concepts that can be immediately applied, including:

• Practical frameworks for analyzing European pricing and reimbursement systems
• Comparative approaches to evaluating reimbursement policies across countries
• Real-world examples illustrating variations in reimbursement and market access decisions
• Insights into how regulatory structures, stakeholder incentives, and national priorities shape pharmaceutical reimbursement outcomes

This course is essential for professionals involved in market access, health economics, regulatory affairs, and policymaking, providing the tools and knowledge needed to navigate the evolving landscape of pharmaceutical reimbursement in Europe.

Register Here

*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.

LEVEL: Intermediate
TRACK: Health Policy & Regulatory

FACULTY MEMBERS